Abstract
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic spreads, it is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to the respiratory system, and that other organs can be affected. In particular, virus-related neurological manifestations are being reported more and more frequently in the scientific literature. In this article, we review the literature on the association between COVID-19 and neurological manifestations, present evidence from preclinical research suggesting that SARS-CoV-2 could be responsible for many of these manifestations, and summarize the biological pathways that could underlie each neurological symptom. Understanding the mechanisms that lead to neurological manifestations in patients with COVID-19 and how these manifestations correlate with clinical outcomes will be instrumental in guiding the optimal use of targeted therapeutic strategies.
TY - JOUR
T1 - Lifting the mask on neurological manifestations of COVID-19.
AU - Pezzini,Alessandro,
AU - Padovani,Alessandro,
Y1 - 2020/08/24/
PY - 2020/07/28/accepted
PY - 2020/8/26/pubmed
PY - 2020/11/5/medline
PY - 2020/8/26/entrez
SP - 636
EP - 644
JF - Nature reviews. Neurology
JO - Nat Rev Neurol
VL - 16
IS - 11
N2 - As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic spreads, it is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to the respiratory system, and that other organs can be affected. In particular, virus-related neurological manifestations are being reported more and more frequently in the scientific literature. In this article, we review the literature on the association between COVID-19 and neurological manifestations, present evidence from preclinical research suggesting that SARS-CoV-2 could be responsible for many of these manifestations, and summarize the biological pathways that could underlie each neurological symptom. Understanding the mechanisms that lead to neurological manifestations in patients with COVID-19 and how these manifestations correlate with clinical outcomes will be instrumental in guiding the optimal use of targeted therapeutic strategies.
SN - 1759-4766
UR - https://www.unboundmedicine.com/medline/citation/32839585/Lifting_the_mask_on_neurological_manifestations_of_COVID_19_
L2 - https://doi.org/10.1038/s41582-020-0398-3
DB - PRIME
DP - Unbound Medicine
ER -